City
Epaper

Horse antisera may be effective treatment for COVID-19: Central Research Institute

By ANI | Published: November 26, 2021 2:37 PM

A team of researchers at Central Research Institute, Kasauli has found that antibodies can be synthesised from the horse and can be injected into humans infected with COVID-19 which can be an efficient approach in future to combat the disease.

Open in App

A team of researchers at Central Research Institute, Kasauli has found that antibodies can be synthesised from the horse and can be injected into humans infected with COVID-19 which can be an efficient approach in future to combat the disease.

"Antisera is basically readymade antibodies. Whenever an infection occurs in the human body, it naturally raises antibodies but that takes some time. It takes around 7 to 14 days when you make your own antibodies against any antigen and they are specific antibodies are meant to favour infection," said Dr Dimple Kasana Director, CRI.

She further explained the process of using such antibodies, "When you say the antisera it means we are making these antibodies artificially. Hence, there is no timeline issue. For example, suppose there is a dog bite, you will not wait 14 days for your antibodies to come, you would want something immediately. So you will raise these antibodies artificially somewhere outside the human body."

"Horse is a larger animal, so if you raise antibodies in a large animal you get a large number of titers. You give this artificial antibody to the person whoever requires it and you immediately have a response that is an immune response," she added.

On the use of such treatment for COVID-19, Dr Dimple said, "So whenever there is COVID infection, we, unfortunately, do not have any specific treatments. So far, it all depends upon the immune response of a person's body. Each person will have a different response, we may give antivirals, you may give steroids, but each person would react differently because the bodies are different. If we make antibodies separately and give them to the person who's having the COVID antigen or the COVID infection, then we do not lose time. There will be an immediate response."

CRI has applied for more permissions for clinical trials of its studies, "From our part, the job is over. We are giving them the results and following up with them. All these things actually require the permission from the government from the regulatory authorities."

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Central research institute
Open in App

Related Stories

InternationalDeath toll after research facility fire in Russia's Tver rises to 17

HealthBharat Biotech dispatches 1st batch of Covaxin for immunisation drive

National Realted Stories

NationalConstituency Watch: Solapur Cong hopes to regain lost glory, BJP aims to score hat-trick by betting big on young blood

NationalNaMo App unveils 'Abki baar 400 paar' module, urges users to become '400 Paar Ambassadors'

NationalBajaj Bruzer 125: World's First CNG Bike Set to Revolutionize Two-Wheeler Market, Launch Date Revealed

NationalTrinamool's corruption akin to UPA's during its 10-year rule: PM Modi

NationalTelangana HC sets aside BRS MLC's election